Psychedelic Biotechs Approaching Phase 3 Trials for CNS Treatments Several psychedelic biotech companies are nearing critical Phase 3 trials, aiming to reshape mental health treatments for depression and anxiety disorders.

Psychedelic Biotechs Approaching Phase 3 Trials for CNS Treatments #USA #Vancouver #mental_health #Helus_Pharma #Psychedelic_Biotechs